# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Jun 21, 2023

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2023-06-21
- Accepted by EDGAR: Jun 21, 2023, 17:00 ET
- Period: 2023-06-21
- Accession: 0001493152-23-022030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315223022030/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315223022030/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315223022030/form8-k.htm

Filed Jun 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-022030. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
